Counterfeit medicines of about ₹2 crores of leading manufacturers seized

Central Drugs Standard Control Organisation (CDSCO) East Zone conducted the raid after getting a complaint.

Updated - August 03, 2023 08:50 pm IST - NEW DELHI

Counterfeit medicines of about ₹2 crores of leading manufacturers of reputed brands were seized from unlicensed premises.

Counterfeit medicines of about ₹2 crores of leading manufacturers of reputed brands were seized from unlicensed premises. | Photo Credit: K.K. Mustafah

Counterfeit medicines of about ₹2 crores of leading manufacturers like Sun Pharmaceutical, Alkem, Cipla, Glenmark, GSK, Abbott, Novartis, Dr. Reddy’s, Aristo of reputed brands like Augmentin, Pan-D, Pantocid DSR, Urimax-D, Clavam, were seized from unlicensed premises situated at 82, Moulana Shaukat Ali Street in Kolkata, said a senior official in the Health Ministry on Thursday.

He added that one person was arrested from the location and was sent in judicial custody for 10 days by Bankshall Court. Further investigation to find the manufacturer and supply chain is ongoing.

Central Drugs Standard Control Organisation (CDSCO) East Zone conducted the raid after getting a complaint from Sun Pharma Laboratories Limited regarding the selling and storage of suspected spurious (counterfeit) of their products 

Earlier a team of officers from CDSCO East Zone conducted a raid at the Bagri Market and seized spurious/counterfeit drugs of leading manufacturers worth approx. ₹10 lakh and one person was arrested in the matter by the Drug Inspector under the provisions of the Drugs & Cosmetics Act, 1940.

On further investigation into the matter and information disclosed during the interrogation of the arrested accused, a breakthrough was obtained, and one unlicensed warehouse was identified at Moulana Shaukat Ali Street. On confirmation of the presence of the suspected person, a goods raid was conducted on July 8 by officers from CDSCO East Zone. 

Also Read | The lowdown on ‘substandard’ cough syrups

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.

  翻译: